Hematologic Oncology | Specialty

The OncLive Hematology Oncology condition center page is a comprehensive resource for clinical news and expert insights on various hematologic malignancies, including leukemias, lymphomas, myeloproliferative neoplasms, multiple myeloma, and much more. This section features news articles, interviews in written and video format, and podcasts that focus on unmet needs, treatment advances, and ongoing research in hematologic cancers.

The Evolving Role of Transplant in ALL

January 22nd 2019

Blinatumomab for Patients with MRD-Positive ALL

January 22nd 2019

Monitoring for Relapse in Acute Lymphoblastic Leukemia

January 22nd 2019

Time Points in the Assessment of MRD

January 22nd 2019

Role of MRD Testing in Adult Acute Lymphocytic Leukemia

January 22nd 2019

Therapeutic Approaches in Philadelphia-like ALL

January 22nd 2019

Revolutionizing the Treatment of Ph+ ALL with TKIs

January 22nd 2019

Considerations of Cytoreduction in ALL

January 22nd 2019

Effective Novel Agents in Upfront Treatment of ALL

January 22nd 2019

How Age Affects Treatment Approaches in ALL

January 22nd 2019

Pediatric-Inspired Regimens in ALL

January 22nd 2019

Molecular Cytogenetic Risk Stratification in ALL

January 22nd 2019

Differentiating BTK Inhibitor Mechanisms of Action in MCL

January 18th 2019

Identifying Unmet Needs in Relapsed/Refractory MCL

January 18th 2019

MCL: Differences in Trial Design Between BTK Inhibitors

January 18th 2019

Personal Insight Into Ibrutinib Use in Mantle Cell Lymphoma

January 18th 2019

Advice for Future Management of Mantle Cell Lymphoma

January 18th 2019

Non-BTKi Agents' Role in Mantle Cell Lymphoma

January 18th 2019

MCL: Novel BTK Inhibitor Combination Strategies

January 18th 2019

Considering Off-Label Use of Ibrutinib in MCL

January 18th 2019